Esperion Therapeutics Inc (ESPR) — Working Capital to Net Assets Ratio
Esperion Therapeutics Inc (ESPR) has a Working Capital to Net Assets ratio of -0.3% as of September 2025. Working capital of $1.43 Million (current assets of $360.46 Million minus current liabilities of $359.03 Million) is measured against net assets of $-451.36 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Esperion Therapeutics Inc balance sheet quality to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Esperion Therapeutics Inc Working Capital to Net Assets (1999–2024)
This chart shows how Esperion Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 18 annual periods from 1999 to 2024. As of September 2025, the ratio stands at -0.3%, reflecting working capital of $1.43 Million against net assets of $-451.36 Million USD. Check ESPR goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Esperion Therapeutics Inc (1999–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Esperion Therapeutics Inc from 1999 to 2024, covering 18 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Esperion Therapeutics Inc market capitalisation.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | -23.6% | $91.77 Million | $-388.72 Million | $338.00 Million | $246.23 Million | ▼ -13.8 pp |
| 2023 | -9.9% | $44.84 Million | $-454.99 Million | $201.06 Million | $156.22 Million | ▲ +37.8 pp |
| 2022 | -47.7% | $154.38 Million | $-323.78 Million | $246.68 Million | $92.31 Million | ▲ +82.1 pp |
| 2021 | -129.8% | $255.62 Million | $-196.94 Million | $328.97 Million | $73.35 Million | ▲ +132.2 pp |
| 2020 | -262.0% | $251.83 Million | $-96.13 Million | $345.90 Million | $94.07 Million | ▼ -991.9 pp |
| 2019 | 730.0% | $145.63 Million | $19.95 Million | $211.71 Million | $66.08 Million | ▲ +631.0 pp |
| 2018 | 99.0% | $78.30 Million | $79.12 Million | $142.63 Million | $64.33 Million | ▲ +29.2 pp |
| 2017 | 69.8% | $170.78 Million | $244.69 Million | $203.92 Million | $33.14 Million | ▼ -16.8 pp |
| 2016 | 86.6% | $197.99 Million | $228.60 Million | $213.58 Million | $15.59 Million | ▲ +13.9 pp |
| 2015 | 72.7% | $208.77 Million | $287.26 Million | $214.39 Million | $5.62 Million | ▼ -3.2 pp |
| 2014 | 75.8% | $101.28 Million | $133.55 Million | $106.77 Million | $5.49 Million | ▼ -0.3 pp |
| 2013 | 76.1% | $56.42 Million | $74.09 Million | $60.62 Million | $4.20 Million | ▲ +18.4 pp |
| 2012 | 57.7% | $-10.03 Million | $-17.39 Million | $7.14 Million | $17.17 Million | ▲ +66.4 pp |
| 2011 | -8.7% | $524.82K | $-6.06 Million | $1.86 Million | $1.34 Million | ▼ -112.8 pp |
| 2002 | 104.1% | $40.33 Million | $38.74 Million | $45.26 Million | $4.93 Million | ▲ +6.5 pp |
| 2001 | 97.6% | $64.93 Million | $66.50 Million | $71.29 Million | $6.36 Million | ▲ +2.8 pp |
| 2000 | 94.8% | $64.18 Million | $67.69 Million | $71.34 Million | $7.16 Million | ▼ -16.8 pp |
| 1999 | 111.6% | $3.14 Million | $2.81 Million | $6.04 Million | $2.90 Million | — |